175 related articles for article (PubMed ID: 16678917)
1. Using positron emission tomography to facilitate CNS drug development.
Lee CM; Farde L
Trends Pharmacol Sci; 2006 Jun; 27(6):310-6. PubMed ID: 16678917
[TBL] [Abstract][Full Text] [Related]
2. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
Bauer M; Langer O; Dal-Bianco P; Karch R; Brunner M; Abrahim A; Lanzenberger R; Hofmann A; Joukhadar C; Carminati P; Ghirardi O; Piovesan P; Forloni G; Corrado ME; Lods N; Dudczak R; Auff E; Kletter K; Müller M
Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488
[TBL] [Abstract][Full Text] [Related]
3. Medical imaging in pharmaceutical clinical trials: what radiologists should know.
Wang YX
Clin Radiol; 2005 Oct; 60(10):1051-7. PubMed ID: 16179164
[TBL] [Abstract][Full Text] [Related]
4. [Strategy for development of imaging biomarkers].
Ishiwata K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
[TBL] [Abstract][Full Text] [Related]
5. Small animal PET in preclinical studies: opportunities and challenges.
Riemann B; Schäfers KP; Schober O; Schäfers M
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
[TBL] [Abstract][Full Text] [Related]
6. [Molecular imaging for drug development].
Watanabe Y
Brain Nerve; 2007 Mar; 59(3):209-14. PubMed ID: 17370646
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
8. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. [Application of pre-clinical PET imaging for drug development].
Tsukada H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
[TBL] [Abstract][Full Text] [Related]
12. Role of in vivo imaging of the central nervous system for developing novel drugs.
Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.
Leopoldo M; Lacivita E; De Giorgio P; Contino M; Berardi F; Perrone R
Bioorg Med Chem; 2009 Jan; 17(2):758-66. PubMed ID: 19081257
[TBL] [Abstract][Full Text] [Related]
14. [Molecular imaging for drug development].
Watanabe Y
Nihon Rinsho; 2007 Feb; 65(2):357-62. PubMed ID: 17302284
[TBL] [Abstract][Full Text] [Related]
15. [Microdose clinical trial--impact of PET molecular imaging].
Yano T; Watanabe Y
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1839-48. PubMed ID: 20948244
[TBL] [Abstract][Full Text] [Related]
16. Adenosine receptor ligands and PET imaging of the CNS.
Bauer A; Ishiwata K
Handb Exp Pharmacol; 2009; (193):617-42. PubMed ID: 19639295
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
18. Using imaging biomarkers to accelerate drug development and clinical trials.
Pien HH; Fischman AJ; Thrall JH; Sorensen AG
Drug Discov Today; 2005 Feb; 10(4):259-66. PubMed ID: 15708744
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen M; Fettig NM; Rossin R
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
[TBL] [Abstract][Full Text] [Related]
20. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
